An observational study in Skin Pigment, sponsored by Integrative Skin Science and Research. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-28.
Sponsored by Integrative Skin Science and Research · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Pigmentation Disorders with a site in United States — 7 open to participants now, 9 under way, none of them phase 3. Pigmentation Disorders · United States.
Among the 25 studies in Pigmentation Disorders with a site in United States, this one is one of 4 that started in 2023, is one of 7 observational ones, and was the 21st registered.
57 studies on the registry are indexed under Pigmentation Disorders; 12 are open to participants now.
Browse Pigmentation Disorders studies →7 of the 25 studies in Pigmentation Disorders with a site in United States are open now. Recruiting first, the newest first:
CERM INC. · Sites in United States
Ages 21–80
Icahn School of Medicine at Mount Sinai · Sites in United States
Ages up to 18
Medstar Health Research Institute · Sites in United States
Ages 18+
University of California, San Francisco · Sites in United States
Ages 18–50 · Healthy volunteers
University of California, Davis · Sites in United States
Ages 18+ · Women only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 9 Pigmentation Disorders studies recruiting now, 4 set no upper age limit and 4 stop at 75 or younger; 1 takes children under 18; 3 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 4 2
First in 2008; this study’s year is marked. 4 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 500 is above the median of 232 across 11 observational studies indexed under Pigmentation Disorders.
Median enrollment 31 across the 18 interventional studies, 500 across the 7 observational. Of the 15 that completed or were terminated, 6 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 25 have an industry lead sponsor. The 10 most frequent:
Integrative Skin Science and Research is the lead sponsor of 35 studies on the registry; 12 are open to participants now.
Integrative Skin Science and Research has 2 studies filed under Pigmentation Disorders — fewer than ten, so there is no comparison to draw.
3 of the studies in Pigmentation Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06063148University of California, DavisNeonatal Pulse Oximetry Disparities Due to Skin Pigmentation | 2026-12 |
| NCT04875715University of California, DavisProspective Evaluation of Topical Almond Oil vs Hydroquinone | 2026-12-01 |
| NCT06575270Icahn School of Medicine at Mount SinaiSkin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD) | 2027-08-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 25 studies in Pigmentation Disorders with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to correlate subjective skin pigment measurements as reported by patient-responses to the Fitzpatrick Skin Type Scale versus objective classification of skin pigment utilizing Individual Typology Angle (ITA) measurements.
The Fitzpatrick scale is a numerical classification for human skin color developed in 1975 as a way to estimate the response of different types of skin to UV light. It is used by dermatologists to classify skin tone and assess the risk of skin cancer.
The Fitzpatrick scale encompasses six gradings, from I to VI. However, this does not include all skin tones, as there are significantly more not encompassed within the scale. The aim of this study is to incorporate objective measurements when identifying a patient's Fitzpatrick skin type.
All subjects, healthy and unhealthy, are eligible to enroll. Subjects from the greater Sacramento region will be enrolled. Subjects must be at least 18 years of age.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This survey and ITA measurements will be performed among the general public
Other: Survey administration for Fitzpatrick skin type · Device: Measurement of ITA based on SkinColorCatch instrument
Survey administration for Fitzpatrick skin type
Measurement of ITA based on SkinColorCatch instrument
Skin colorimeter derived Individual Typology Angle value correlated against self-reported Fitzpatrick skin type
Correlation of ITA by the use of SkinColorCatch (Delfin) compared to the Fitzpatrick skin scale as determined by the patients' responses to validated questionnaire. The higher the ITA, the lighter the skin. ITA skin color types are classified into six groups, from Very Light to Dark skin.
Time frame: One time - collected for up to 1 year for the entire study
Assess Fitzpatrick Skin type based on validated questionnaire
Questionnaire about sun sensitivity and tanning will be administered to calculate the Fitzpatrick skin types
Time frame: One time - collected for up to 1 year for the entire study
Sun protection habit use
Quantification of sun protection habits based on survey question asking their typical use of sun protection
Time frame: One time - collected for up to 1 year for the entire study
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2023 (actual). Primary completion is estimated for May 2024, 6 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Integrative Skin Science and Research →